Stock listing
NASDAQ:MPLT MapLight Therapeutics, Inc. Stock
Home listing (NASDAQ) of MapLight Therapeutics, Inc.
Follow MapLight Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:MPLT
$7.70 USD -0.32 (-4.0%)
Close on Oct 16, 2026
- Ticker
- NASDAQ:MPLT
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Oct 6, 2026
MapLight Therapeutics Celebrates Co-Founder Dr. Karl Deisseroth on Receipt of 2026 Nobel Prize in Physiology or Medicine for the Development of Optogenetics
Latest deck · Aug 13, 2026
Investor Presentation (August 2026)
Investor deck · 28 slides
Latest news
Financings
Private placement of common stock and pre-funded warrants
Aug 13, 2026
Announced: about US$150M · US$11.38 a share · Morgan Stanley +3
Dealers: Morgan Stanley, Jefferies, Leerink Partners, Stifel
Use of proceeds: Advance ML-007C-MA, including the VISTA Phase 2 and ZEPHYR-2 Phase 3 studies, plus working capital and general corporate purposes
Decks
Investor Presentation (August 2026)
Investor deck · 28 slides · Aug 13, 2026
Technical Presentation (July 2026)
Technical · 27 slides · Jul 27, 2026
Technical Presentation (June 2026)
Technical · 21 slides · Jun 22, 2026
Investor Presentation (May 2026)
Investor deck · 34 slides · May 14, 2026
MapLight Therapeutics, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 16 in the last 12 months · 16 in all · newest Oct 6, 2026 · oldest 2025
- Decks
- 7 decks · latest Aug 13, 2026
Where MapLight Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MPLT · Home listing · This page | NASDAQ | United States | USD |
| BOATS:MPLT | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about MapLight Therapeutics, Inc.